Humans who are homozygous for inactivating mutations in LRP5 develop osteoporosis pseudoglioma (OPPG), a syndrome characterized by bone and eye abnormalities (Gong et al., 2001). This evidence concerns the gene LRP5 and Osteoporosis - pseudoglioma.